Estimated prevalence of Alzheimer's disease in the United States.
about
Economic considerations in the management of Alzheimer's diseaseHuperzine A for Alzheimer's diseaseHuperzine A for Alzheimer's diseaseA molecular link between the active component of marijuana and Alzheimer's disease pathologyCurrent pharmacologic options for patients with Alzheimer's diseaseThe Epidemiological Scale of Alzheimer's DiseaseEvidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's DiseaseAdvanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.Musical experience and dementia. Hypothesis.Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease.Pharmacologic management of Alzheimer disease, Part I: Hormonal and emerging investigational drug therapies.RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1Vitamin D and neurocognitive dysfunction: preventing "D"ecline?Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study.Marital quality in the context of mild cognitive impairmentSubtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline.Dementia in the elderly: the "silent epidemic" no more.Effects of the Medicare Alzheimer's disease demonstration on Medicare expenditures.Long-term care eligibility criteria for people with Alzheimer's diseasePsychosocial interventions for caregivers of people with dementia: a systematic review.The costs of caring: medical costs of Alzheimer's disease and the managed care environment.National estimates of the prevalence of Alzheimer's disease in the United States.The search for the ideal SERM.Effect of vascular lesions on cognition in Alzheimer's disease: a community-based studySources of variability in estimates of the prevalence of Alzheimer's disease in the United States.Changes in the prevalence of cognitive impairment among older Americans, 1993-2004: overall trends and differences by race/ethnicity.The measurement of everyday cognition: development and validation of a short form of the Everyday Cognition scalesA simple method to rule out dementia with temporal orientation.Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.A longitudinal analysis of the lifetime cost of dementia.Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans.Alzheimer's and dementia in the oldest-old: a century of challengesFatty acid oxidation in the pathogenesis of Alzheimer's disease.Examining the Association Between Quadriceps Strength and Cognitive Performance in the ElderlyHigh normal plasma triglycerides are associated with preserved cognitive function in Chinese oldest-old.Recognition and treatment of Alzheimer's disease: a case-based review.The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's diseasePractical utility of urinary assay in the diagnosis of Alzheimer's disease: AlzheimAlert.Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.Prevalence of cognitive impairment without dementia in the United States.
P2860
Q22241448-5F28F1FE-3DC5-43F1-9A70-94B0FD2997F2Q24243171-821BB33F-9E6F-4F89-A9CD-EC525037F132Q24245024-B51B285F-3AF8-4EFD-AD51-B0E015BF5980Q24657485-222EEFB3-18AB-4865-BCD0-249F451D5DEBQ24800530-97B3CBDF-4741-4AF7-9314-05FEFE8FBFF4Q26801246-89415291-D115-45D7-A682-40A7422294CCQ28212725-C984ADDF-4C46-4236-8DC9-91AA027F6FD8Q30426453-9E9E2F72-D72E-43DF-BFCF-6CBB56D61D50Q30541222-5F6E6E95-30AA-4E95-8BFC-785E4F9A3FE7Q30887180-E1EFF04A-4F48-4EF3-9192-D6EF9633E214Q33543110-168A5676-F700-4F8C-8C61-1BD095F19D53Q33607305-C58B7145-DBBE-4B35-8D7F-2F998DA80D55Q33693884-C3E97C95-5DB6-4F5B-BDBE-820AD9B1953CQ33750604-ED321C1E-C20F-4B47-B29E-C3D4B633079EQ33827876-570EEF27-357E-467B-9420-2DCE3C240DEDQ33987715-1FE8B754-7705-496D-9D16-14E1BE9E01E2Q34286598-E5A2DF7D-C589-458B-9380-F5969C55B01CQ34324520-318F8387-E823-4D68-9361-86A6C85060CBQ34326803-9C4E606E-854D-4F53-A9DB-C850E5BAC7FCQ34340466-2C239387-3E07-45CE-AA25-D242E989E2A8Q34496154-79E85A28-B3A7-46D0-8B7B-FF7B032C7D0BQ34640141-3EA72E46-CA23-4D2E-AADC-AC8C642DE918Q34660744-547CA157-7746-431F-8D23-8EB77524CAE7Q34709029-85FD0A54-87D9-4786-B299-7A1C577264FBQ35133019-5D6969A8-6EA1-4055-AE31-7F7303EF5333Q35450588-BA2BCB4A-3D30-43E4-AF38-9BD38D25B4F4Q35536332-7845869A-2A73-415F-9B66-79BA7D74D76EQ35570896-5DA34825-BEB5-4208-BFD9-C7FF3B700D7BQ35758632-184C9520-1B62-42E6-8AEF-169DE98C6197Q35840191-6C5A268B-E858-4F66-BF64-CBFEE9190ECAQ35936632-7B8DBA80-7F49-44CE-921E-AD79AA2B6560Q36026972-78A6F43D-0629-48EB-8D87-3A95C905C513Q36108432-269B39EA-9BD5-417C-8508-ECF39D411C26Q36195056-FF4EF7EC-1654-4229-9ED5-77837D04C6AEQ36407294-E8CF41EC-5B34-429E-90F1-3A65CD2D2D3FQ36458308-130DB07B-0AF3-42A0-A643-AFD341384B26Q36955530-867C9A65-0F3B-4D60-87E6-CDD63C7032D5Q37035260-FEFB76A0-CEC5-441D-A317-8F2A1A6FCD85Q37035610-D578AB4D-51F1-4353-87F7-C485C305E164Q37161762-320A35C6-1AC7-4D8E-BA09-6B91A92CB3F0
P2860
Estimated prevalence of Alzheimer's disease in the United States.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Estimated prevalence of Alzheimer's disease in the United States.
@en
type
label
Estimated prevalence of Alzheimer's disease in the United States.
@en
prefLabel
Estimated prevalence of Alzheimer's disease in the United States.
@en
P356
P1433
P1476
Estimated prevalence of Alzheimer's disease in the United States.
@en
P2093
P304
P356
10.2307/3350099
P407
P577
1990-01-01T00:00:00Z